Kevin Hassett, left, the director of the U.S. National Economic Council, with Pascal Soriot, AstraZeneca’s chief executive, and Gov. Glenn Youngkin of Virginia, in Washington on Monday.
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
Published on July 22, 2025
United States Politics and GovInternational Trade and World Drugs (Pharmaceuticals)Customs (Tariff)Factories and ManufacturingRelocation of BusinessAstraZeneca PLCTrump, Donald JHassett, Kevin ASoriot, Pascal